Ono Pharmaceutical Co Ltd 2014 SR
The report highlights Ono Pharmaceutical's commitment to developing innovative drugs under its philosophy "Dedicated to Man's Fight against Disease and Pain." Key achievements in fiscal year 2013 include the introduction of a new CSR management system with PDCA tables and the expansion of the development pipeline, notably in oncology. The company achieved a 5.16% reduction in energy consumption at production and research sites and maintained a high employment rate for persons with disabilities at 2.30%. Additionally, Ono Pharmaceutical celebrated the 25th anniversary of the Ono Medical Research Foundation and launched specialized websites to support patients with dementia and cancer.
Company: Ono Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2014
Type: SR
Pages: 28
Ono Pharmaceutical Co Ltd
CSR Report
The report highlights Ono Pharmaceutical's commitment to developing innovative drugs under its philosophy "Dedicated to Man's Fight against Disease and Pain." Key achievements in fiscal year 2013 include the introduction of a new CSR management system with PDCA tables and the expansion of the development pipeline, notably in oncology. The company achieved a 5.16% reduction in energy consumption at production and research sites and maintained a high employment rate for persons with disabilities at 2.30%. Additionally, Ono Pharmaceutical celebrated the 25th anniversary of the Ono Medical Research Foundation and launched specialized websites to support patients with dementia and cancer.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Apr 1, 2013 - Mar 31, 2014
Fiscal Year
2013
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Employees